Mavik and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mavik (trandolapril) and Lantus (insulin glargine recombinant). Common drug interactions include cognitive disorder among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Mavik and Lantus. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Mavik?

Mavik has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 3,145 Mavik users. Check the latest studies of Mavik.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

On Jul, 10, 2026

65 people who take Mavik and Lantus together, and have interactions are studied.

What are the common drug interactions of Mavik and Lantus, by gender? *:

female:

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Diplopia (double vision)
Dysarthria (speech disorder)
Facial bones fracture (bone fracture of face)
Gait disturbance
Gallbladder disorder
Hemiparesis (weakness on one side of the body)
Hypoaesthesia (reduced sense of touch or sensation)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Hypotension (abnormally low blood pressure)

male:

Nausea (feeling of having an urge to vomit)
Weight decreased
Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Erectile dysfunction
Eye disorder
Fatigue (feeling of tiredness)
General physical health deterioration (weak health status)
Headache (pain in head)

What are the common drug interactions of Mavik and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Arterial rupture
Arteriovenous malformation
Arthralgia (joint pain)
Blood glucose increased
Bone pain
Deformity (disfigurement)
Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
Eye disorder
General physical health deterioration (weak health status)
Joint range of motion decreased (disease of joint movement)

40-49:

Anterograde amnesia (loss of memory for events after an incident)
Autonomic neuropathy (malfunction of the autonomic nervous system (ans))
Blood glucose increased
Chest pain
Claustrophobia (fear of having no escape and being closed in small spaces)
Constipation
Conversion disorder (neurological symptoms, such as numbness, blindness, paralysis, or fits without a definable organic cause)
Diabetes mellitus inadequate control
Diarrhoea
Glycosylated haemoglobin increased

50-59:

Hypotension (abnormally low blood pressure)
Malaise (a feeling of general discomfort or uneasiness)
Muscle twitching
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pain in extremity
Pancreatic injury
Renal failure acute (rapid kidney dysfunction)
Pancreatitis (inflammation of pancreas)
Weight decreased
Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)

60+:

Blood glucose increased
Nausea (feeling of having an urge to vomit)
Dyspnoea (difficult or laboured respiration)
Eye disorder
Fall
General physical health deterioration (weak health status)
Joint range of motion decreased (disease of joint movement)
Muscular weakness (muscle weakness)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema peripheral (superficial swelling)

What are the existing conditions these people have? *

Type 2 Diabetes: 13 people, 20.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 10.77%
Depression: 6 people, 9.23%
Stress And Anxiety: 5 people, 7.69%
Insomnia (sleeplessness): 4 people, 6.15%
Headache (pain in head): 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Mavik and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously